US Patent Issued to KANGMA-HEALTHCODE (SHANGHAI) BIOTECH on Feb. 3 for "ADH protein family mutant and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,313, issued on Feb. 3, was assigned to KANGMA-HEALTHCODE (SHANGHAI) BIOTECH Co. LTD. (Shanghai).

"ADH protein family mutant and use thereof" was invented by Min Guo (Shanghai), Mini Deng (Shanghai) and Xue Yu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an ADH protein mutant and the use thereof. Compared with a wild-type ADH protein, the mutant is capable of (i) enhancing the expression purity, efficiency and yield of exogenous proteins in an in-vitro cell-free synthesis system; and/or (ii) reducing the binding ability of the mutant protein to Ni medium."

The patent was filed on May 28, 2019, under Application No. 17/059,416...